Infant with cardiomyopathy: When to suspect inborn errors of metabolism?

Stephanie L Byers1, Can Ficicioglu1

  • 1Stephanie L Byers, Can Ficicioglu, The Children's Hospital of Philadelphia, Section of Metabolic Disease, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, United States.

World Journal of Cardiology
|November 28, 2014
PubMed

Insights

Inborn errors of metabolism are found in 5%-26% of pediatric cardiomyopathy cases. This review highlights key indicators for suspecting metabolic disorders and referring patients for specialized evaluation.

Area of Science:

  • Metabolic disorders
  • Cardiology
  • Pediatrics

Background:

  • Inborn errors of metabolism (IEM) are identified in 5%-26% of infants and children diagnosed with cardiomyopathy.
  • While fatty acid oxidation disorders, lysosomal and glycogen storage disorders, and organic acidurias are established causes, emerging evidence points to mitochondrial dysfunction and congenital disorders of glycosylation.

Purpose of the Study:

  • To guide primary care physicians and cardiologists in identifying patients with cardiomyopathy who may have an underlying inborn error of metabolism.
  • To outline specific "red flags" prompting referral to a metabolic specialist for further diagnostic workup.

Main Methods:

  • This is a review article.
  • It synthesizes current knowledge on IEM associated with cardiomyopathy.
  • It focuses on clinical indicators and diagnostic referral criteria.

Main Results:

  • A significant proportion of pediatric cardiomyopathies are linked to IEM.
  • Recognizing specific clinical signs and symptoms is crucial for early diagnosis.
  • Timely referral to metabolic specialists improves patient management.

Conclusions:

  • Primary care physicians and cardiologists should maintain a high index of suspicion for IEM in children with cardiomyopathy.
  • Prompt metabolic workup is essential for patients presenting with suggestive "red flags".
  • Early identification and management of IEM can improve outcomes in pediatric cardiomyopathy.

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
1.1K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
889
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
373
Protein Import into the Peroxisomes01:27

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
5.7K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.8K